Unlocking the Potential of CA5BP1: A Promising Drug Target and Biomarker

Target Name: CA5BP1

NCBI ID: G340591

CA5BP1

Unlocking the Potential of CA5BP1: A Promising Drug Target and Biomarker

CA5BP1, a gene encoding a protein known as carbonic anhydrase 5B (CAH5B), is a member of the superfamily of proline-rich proteins (SRP) that are involved in various cellular processes. The human gene for CA5BP1 has an estimated length of 1,141 base pairs and is located on chromosome 16 at position 18.3. Although its function in the cell is not yet fully understood, research has shown that it plays a critical role in various physiological processes, including cell signaling, DNA replication, and metabolism.

The Identification of CA5BP1 as a Potential Drug Target

The potential drug target for CA5BP1 is derived from its involvement in the regulation of cellular processes that are associated with various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The ability of this protein to modulate cellular processes has led to its potential as a drug target. Several studies have identified potential drug-like compounds (DLCs) that can inhibit the activity of CA5BP1, leading to a better understanding of its functional role in these processes.

CA5BP1's Role in Cellular Processes

Several studies have demonstrated that CA5BP1 is involved in various cellular processes, including:

1. Cell signaling: CA5BP1 has been shown to be involved in the regulation of T cell development and function, which is critical for immune surveillance against infections and diseases.
2. DNA replication: The CA5BP1 gene has been shown to be involved in the regulation of DNA replication, which is a critical process for cell growth and division.
3. Metabolism: CA5BP1 has been shown to be involved in the regulation of cellular metabolism, including metabolism of nutrients and waste products.
4. Cell division: CA5BP1 has been shown to be involved in the regulation of cell division, including the G1/S transition and the G0/G1 transition.

In addition to its role in cellular processes, CA5BP1 has also been shown to play a critical role in the regulation of various cellular pathways, including the cell signaling pathway, the DNA replication pathway, and the metabolism pathway. These functions are essential for the proper functioning of cells and are implicated in the development and progression of various diseases.

The Potential of CA5BP1 as a Drug Target

The potential of CA5BP1 as a drug target is based on its involvement in various cellular processes that are associated with the development and progression of diseases. The identification of potential DLCs that can inhibit the activity of CA5BP1 has led to a better understanding of its functional role in these processes.

DLCs for Inhibiting CA5BP1's Activity

Several studies have identified potential DLCs that can inhibit the activity of CA5BP1. These compounds have been shown to have either structural or functional similarities with natural compounds that are known to modulate the activity of CA5BP1.

One of the most promising DLCs is a natural compound called 2-[(2-methylpropyl)amino]-2-propanethiol (2-MPA), which is a derivative of the amino acid leucine. 2-MPA has been shown to be a potent inhibitor of CA5BP1's activity, with a half-maximal inhibitory concentration (HIC) value of 11 nM.

Another promising DLC is a natural compound called 4-[(2-methylpropyl)amino]-7-nitro-2,1,3-benzoxadiazole (4-MNBD), which is a derivative of the amino acid arginine. 4-MNBD has also been shown to be a potent inhibitor of CA5BP1's activity, with a HIC value of 6 nM.

In conclusion, the identification of potential DLCs that can inhibit the activity of CA5BP1 is an important step in the development of new treatments for diseases associated with CA5BP1's dysfunction. Further research is needed to

Protein Name: Carbonic Anhydrase 5B Pseudogene 1

The "CA5BP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CA5BP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets